According to current study findings, the guideline from ADA 2023 has designated SGLT-2i and GLP-1 RAs as first-line drugs for T2DM patients with established ASCVD or high cardiovascular risk, and metformin is no longer recommended as first-line therapy for T2DM patients with high cardiovascular risk due to its neutral HF benefits
What is the best peptide for muscle growth
If your primary electrolyte source has been food rather than supplementation, reduced intake will amplify the keto-induced losses
Zeng T, Li J, Xie L, Dong Z, Chen Q, Huang S, Xie S, Lai Y, Li J, Yan W, Wang Y, Xie Z, Hu C, Zhang J, Kuang S, Song Y, Gao L, Lv Z (2023) Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
PLoS ONE 10 , (2015)